600196.SS

Shanghai Fosun Pharmaceutical Group Co Ltd · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$9.46B

PE Ratio

18.53

EV to Ebitda

—

Earnings Yield

5.00%

Revenue (TTM)

$6.21B

Net Income (TTM)

$510.4M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

7.00%

Profit Margin

8.00%

Return on Equity

—

Debt to Equity Ratio

0.59

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$9.46B

Revenue TTM$6.21B

Shares Outstanding2.12B

Float1314192604

Insider Ownership43.00%

Institutional Ownership11.00%

Growth Estimates6 fields›

Revenue Growth (Quarterly YoY)7.00%

Rev Growth Est 1Y Forward0.04

EPS Growth (Quarterly YoY)14.00%

EPS Growth Est Quarterly0

FCF Growth (Quarterly YoY)-191.00%

Dividend Growth (Quarterly YoY)-180.00%

Operations19 fields›

Revenue TTM$6.21B

Gross Margin TTM50.00%

Gross Margin (Quarterly)50.00%

Operating Margin TTM8.00%

Operating Margin (Quarterly)8.00%

Operating Expenses TTM$180.9M

Profit Margin TTM8.00%

Profit Margin (Quarterly)9.00%

Net Income TTM$510.4M

EPS TTM1.31

EPS (Quarterly)0.41

EBIT Margin TTM11.38%

EBITDA Margin TTM15.00%

EBITDA TTM$907.0M

CFO TTM$859.4M

Capex % of Revenue TTM10.00%

Capital Expenditures$649.1M

FCF % of Revenue (Quarterly)4.00%

FCF TTM$226.4M

Efficiency1 fields›

ROA2.00%

Valuation9 fields›

P/E (TTM)18.53

P/E Forward17.76

P/FCF41.78

EV/Revenues (TTM)2.03

Price To Book1.31

Price to Tangible Book3.85

Earnings Yield5.00%

FCF Yield2.00%

Payout Ratio24.00%

Liquidity9 fields›

Cash Per Share5.8

Current Ratio0.93

Goodwill & Intangibles$32417.99T

Total Assets$18.05B

Total Liabilities$34.22B

Shareholders Equity$7.22B

Debt to Equity0.59

Interest Expense$180.9M

Goodwill % of Assets26363296.00%

Yields3 fields›

Payout Ratio24.00%

Earnings Yield5.00%

Buyback Yield0.00%